Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Mohammad R. Mohebian, Hamid R. Marateb, Marjan Mansourian, Miguel Angel Mañanas, Fariborz Mokarian
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
Computer-aided diagnosis in medical imaging: historical review, current status and future potential
10.1016/j.compmedimag.2007.02.002 · 2007
Computer aided detection (CAD): an overview
10.1102/1470-7330.2005.0018 · 2005
A review of computer-aided diagnosis of breast cancer: toward the detection of subtle signs
10.1016/j.jfranklin.2006.09.003 · 2007
Computer-aided diagnosis for lung cancer
2004
A computer-aided ECG diagnostic tool
10.1016/j.cmpb.2006.01.003 · 2006
Progress of computer-aided detection/diagnosis (CAD) in dentistry CAD in dentistry
10.1016/j.jdsr.2014.03.002 · 2014
10.1016/j.csbj.2014.11.005
10.1016/j.csbj.2014.11.005
Advances in computer-aided diagnosis for breast cancer
10.1097/01.gco.0000192965.29449.da · 2006
10.1007/s11095-008-9661-9
10.1007/s11095-008-9661-9
Tobacco use and cancer causation: association by tumour type
10.1046/j.1365-2796.2002.01022.x · 2002
Unresolved referenced work
2014
Cancer statistics, 2014
10.3322/caac.21208 · 2014
10.3322/caac.21262
10.3322/caac.21262
Chemoprevention of breast cancer
10.2146/ajhp070663 · 2008
Cancer incidence and mortality in Iran
2009
Incidence of primary breast cancer in Iran: ten-year national cancer registry data report
10.1016/j.canep.2015.04.016 · 2015
Cancer incidence and prevalence in Isfahan: application of mortality data to estimates and projects for the period 2001–2015
10.4103/2008-7802.104858 · 2012
Epidemiology and trend of cancer in Isfahan 2005–2010
2011
10.1186/bcr1639
10.1186/bcr1639
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
10.1016/s1470-2045(12)70137-7 · 2012
Radiation therapy in early-stage invasive breast cancer
10.1007/s13193-011-0048-8 · 2011
10.1200/jco.1996.14.10.2738
10.1200/jco.1996.14.10.2738
10.3322/caac.20107
10.3322/caac.20107
High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1cm or smaller
10.1200/jco.2009.23.2025 · 2009
Relationship between cancer patients' predictions of prognosis and their treatment preferences
10.1001/jama.279.21.1709 · 1998
10.1016/j.artmed.2009.07.008
10.1016/j.artmed.2009.07.008
The Nottingham prognostic index in primary breast cancer
10.1007/bf01840834 · 1992
Development of novel breast cancer recurrence prediction model using support vector machine
10.4048/jbc.2012.15.2.230 · 2012
Using three machine learning techniques for predicting breast cancer recurrence
2013
Exploring factors related to metastasis free survival in breast cancer patients using Bayesian cure models
10.7314/apjcp.2014.15.22.9673 · 2014
PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2
10.1038/bjc.2012.338 · 2012
Breast cancer recurrence according to molecular subtype
10.7314/apjcp.2014.15.14.5539 · 2014
Manipulating measurement scales in medical statistical analysis and data mining: a review of methodologies
2014
An introduction to variable and feature selection
2003
10.1093/bioinformatics/btm344
10.1093/bioinformatics/btm344
Unresolved referenced work
2007
Unresolved referenced work
2014
The appropriateness of the Wilcoxon test in ordinal data
10.1002/(sici)1097-0258(19960330)15:6<631::aid-sim206>3.0.co;2-6 · 1996
10.1007/bf00116251
10.1007/bf00116251
Unresolved referenced work
2014
A k-sample slippage test for an extreme population
10.1214/aoms/1177730290 · doi-reference
10.1007/0-387-25465-x_40
10.1007/0-387-25465-x_40 · doi-reference
A hybrid intelligent system for diagnosing microalbuminuria in type 2 diabetes patients without having to measure urinary albumin
10.1016/j.compbiomed.2013.11.006 · doi-reference
10.1007/bfb0040812
10.1007/bfb0040812 · doi-reference
Applications of multiple imputation in medical studies: from AIDS to NHANES
10.1177/096228029900800103 · doi-reference
Comparison of recurrence and survival rates after breast-conserving therapy and mastectomy in young women with breast cancer
10.3747/co.20.1543 · doi-reference
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
10.1016/s0140-6736(05)66544-0 · doi-reference
Insights into the role of progesterone receptors in breast cancer
10.1200/jco.2005.05.152 · doi-reference
Recurrence-free survival in breast cancer improved by adjuvant tamoxifen — especially for progesterone receptor positive tumors with a high proliferation
10.1007/bf00690181 · doi-reference
10.1038/bjc.2013.756
10.1038/bjc.2013.756 · doi-reference
Interrelationships between Ki67, HER2/neu, p53, ER, and PR status and their associations with tumor grade and lymph node involvement in breast carcinoma subtypes: retrospective-observational analytical study
10.1097/md.0000000000001359 · doi-reference
Prognostic significance of the number of axillary lymph nodes removed in patients with node-negative breast cancer
10.1200/jco.2002.07.112 · doi-reference
Identifying good prognosis group of breast cancer patients with 1–3 positive axillary nodes for adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapy
10.1093/jjco/hyi143 · doi-reference
Predictive model of axillary lymph node involvement in women with small invasive breast carcinoma: axillary metastases in breast carcinoma
10.1002/cncr.10229 · doi-reference
Prognostic value of lymph node ratio in node-positive breast cancer in Egyptian patients
10.1016/j.jnci.2013.10.001 · doi-reference
The lymph node ratio as prognostic factor in node-positive breast cancer
10.1016/j.radonc.2003.10.015 · doi-reference
Cancer of the breast: size of neoplasm and prognosis
10.1002/1097-0142(196911)24:5<1071::aid-cncr2820240533>3.0.co;2-h · doi-reference
Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up
10.1200/jco.1993.11.11.2090 · doi-reference
Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases
10.1002/1097-0142(19890101)63:1<181::aid-cncr2820630129>3.0.co;2-h · doi-reference
Node-negative breast cancer: prognostic subgroups defined by tumor size and flow cytometry
10.1200/jco.1990.8.12.2040 · doi-reference
Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancer
10.1007/bf01806246 · doi-reference
Predicting distant dissemination in patients with early breast cancer
10.1080/02841860701829661 · doi-reference
Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials
10.1200/jco.2001.19.6.1688 · doi-reference
10.1634/theoncologist.9-6-606
10.1634/theoncologist.9-6-606 · doi-reference
Patient and tumor characteristics associated with increased mortality in young women (< or =40years) with breast cancer
10.1002/jso.21268 · doi-reference
Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: long-term results of European Organisation for Research and Treatment of Cancer studies
10.1016/j.ejca.2005.10.006 · doi-reference
Tumour size predicts long-term survival among women with lymph node-positive breast cancer
10.3747/co.19.1043 · doi-reference
The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes
10.1002/cncr.20969 · doi-reference
Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy
10.1007/s10549-008-0160-9 · doi-reference
Breast cancer before age 40years
10.1053/j.seminoncol.2009.03.001 · doi-reference
Feature selection via discretization
10.1109/69.617056 · doi-reference
A noninvasive method for coronary artery diseases diagnosis using a clinically-interpretable fuzzy rule-based system
10.4103/1735-1995.156159 · doi-reference
Application of the McNemar test to non-independent matched pair data
10.1002/sim.4780101211 · doi-reference
Approximate statistical tests for comparing supervised classification learning algorithms
10.1162/089976698300017197 · doi-reference
10.1017/cbo9780511761676
10.1017/cbo9780511761676 · doi-reference
Hypothesis testing, type I and type II errors
10.4103/0972-6748.62274 · doi-reference
Breast cancer detection with reduced feature set
10.1155/2015/265138 · doi-reference
10.1016/s0895-4356(03)00177-x
10.1016/s0895-4356(03)00177-x · doi-reference
10.1109/tkde.2005.50
10.1109/tkde.2005.50 · doi-reference
10.1002/9781119952954
10.1002/9781119952954 · doi-reference